The conference co-hosts would like to thank the members of Advisory Committee for their guidance on the planning of the conference.
Co-Hosts
Edward Abrahams, Ph.D.
President
Personalized Medicine Coalition
Margaret Foti, Ph.D., M.D. (h.c.)
Chief Executive Officer
American Association for Cancer Research
Marcia A. Kean
Chairman
Feinstein Kean Healthcare
Advisory Committee Members
Amy Abernethy, M.D.
Associate Professor of Medicine, Division of Medical Oncology, Department of Medicine,
Duke University School of Medicine
Director, Duke Cancer Care Research Program
Anna Barker, Ph.D.
Director, Transformative Healthcare Networks
Co-Director, Complex Adaptive Systems Initiative
Professor, School of Life Sciences
Arizona State University
Ken Buetow, Ph.D.
Director of Computational Sciences and Informatics
Complex Adaptive Systems Initiative
Arizona State University
Randy Burkholder
Deputy Vice President
Pharmaceutical Research and Manufacturers of America (PhRMA)
William S. Dalton, Ph.D., M.D.
President, CEO, and Center Director
H. Lee Moffitt Cancer Center and Research Institute
Felix W. Frueh, Ph.D.
President
Medco Research Institute, LLC
Express Scripts, Inc.
Richard B. Gaynor, M.D.
Vice President for Clinical Development and Medical Affairs
Oncology Business Unit
Eli Lilly and Company
Lawrence J. Lesko, Ph.D., F.C.P.
Professor and Director
Center for Pharmacometrics and Systems Pharmacology
University of Florida College of Pharmacy (Lake Nona)
J. Leonard Lichtenfeld, M.D., MACP
Deputy Chief Medical Officer
American Cancer Society
John Mendelsohn, M.D.
Past President
Director, Khalifa Institute for Personalized Cancer Therapy
The University of Texas MD Anderson Cancer Center
Laura van‘t Veer, Ph.D.
Leader, Breast Oncology Program
Director, Applied Genomics
UCSF Helen Diller Family Comprehensive Cancer Center